Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified. [electronic resource]
- American journal of medical genetics. Part A Jul 2015
- 1605-9 p. digital
Publication Type: Case Reports; Journal Article
1552-4833
10.1002/ajmg.a.37015 doi
Anemia, Megaloblastic--drug therapy Base Sequence Child, Preschool Diabetes Mellitus--drug therapy Hearing Loss, Sensorineural--drug therapy Homozygote Humans Lithuania Male Membrane Transport Proteins--genetics Molecular Sequence Data Mutation, Missense--genetics Sequence Analysis, DNA Thiamine--therapeutic use Thiamine Deficiency--congenital Treatment Outcome